Evidence map›Paper›PMID 26331111›Full record

ArticleCardiovascular diagnosis and therapy2015

Prevalence of metabolic syndrome in the clinical practice of general medicine in Italy.

Giuliano Tocci, Andrea Ferrucci, Graziella Bruno, Elmo Mannarino, Giulio Nati, Bruno Trimarco, Massimo Volpe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardiovascular diagnosis and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Giuliano Tocci1 Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy ; 2 IRCCS Neuromed Institude, Pozzilli, IS, Italy ; 3 Department of Internal Medicine, University of Turin, Turin, Italy ; 4 Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy ; 5 Società Italiana Medici Generici (SIMG), Rome, Italy ; 6 Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II, Naples, Italy.
Andrea Ferrucci1 Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy ; 2 IRCCS Neuromed Institude, Pozzilli, IS, Italy ; 3 Department of Internal Medicine, University of Turin, Turin, Italy ; 4 Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy ; 5 Società Italiana Medici Generici (SIMG), Rome, Italy ; 6 Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II, Naples, Italy.
Graziella Bruno1 Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy ; 2 IRCCS Neuromed Institude, Pozzilli, IS, Italy ; 3 Department of Internal Medicine, University of Turin, Turin, Italy ; 4 Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy ; 5 Società Italiana Medici Generici (SIMG), Rome, Italy ; 6 Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II, Naples, Italy.
Elmo Mannarino1 Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy ; 2 IRCCS Neuromed Institude, Pozzilli, IS, Italy ; 3 Department of Internal Medicine, University of Turin, Turin, Italy ; 4 Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy ; 5 Società Italiana Medici Generici (SIMG), Rome, Italy ; 6 Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II, Naples, Italy.
Giulio Nati1 Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy ; 2 IRCCS Neuromed Institude, Pozzilli, IS, Italy ; 3 Department of Internal Medicine, University of Turin, Turin, Italy ; 4 Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy ; 5 Società Italiana Medici Generici (SIMG), Rome, Italy ; 6 Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II, Naples, Italy.
Bruno Trimarco1 Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy ; 2 IRCCS Neuromed Institude, Pozzilli, IS, Italy ; 3 Department of Internal Medicine, University of Turin, Turin, Italy ; 4 Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy ; 5 Società Italiana Medici Generici (SIMG), Rome, Italy ; 6 Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II, Naples, Italy.
Massimo Volpe1 Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy ; 2 IRCCS Neuromed Institude, Pozzilli, IS, Italy ; 3 Department of Internal Medicine, University of Turin, Turin, Italy ; 4 Internal Medicine, Angiology and Arteriosclerosis Diseases, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy ; 5 Società Italiana Medici Generici (SIMG), Rome, Italy ; 6 Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II, Naples, Italy.
Molecular Medicine Ireland · IESapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevalence of metabolic syndrome (MS) in the clinical practice is still debated, due to different diagnostic criteria, target populations and clinical settings. Thus, the main purposes of the study were: (I) to evaluate prevalence of MS; (II) to estimate prevalence of additional cardiovascular (CV) risk factors and concomitant conditions in patients with MS followed by general practitioners (GPs) in Italy.

methodsGPs from three different macro-areas were asked to evaluate the first and the last three outpatients, consecutively seen during 20 consecutive weeks in 2007, whatever the reason for clinical consultation. MS was defined according to Adult Treatment Panel (ATP) III definition. Clinical data were collected locally and centrally analysed.

resultsThe overall population sample included 4,513 outpatients, among which 1,574 (34.9%) from Regione Lazio, 1,498 (33.2%) from Regione Piemonte, and 1,441 (31.9%) from Regione Umbria. The population analysis included 4,418 (97.9%) adult outpatients [52.1% females, (mean age, 58.0±11.8 years); mean body mass index (BMI), 26.7±4.7 kg/m(2)]. MS was diagnosed in 1,456 (33.0%) outpatients. High-normal blood pressure (BP) was the most common risk factor for MS (n=1,382; 94.9%), followed by abdominal obesity (n=1,229; 84.4%), hypertriglyceridemia (n=1,032; 70.9%), abnormal fasting glucose (n=819; 56.3%) and low high-density lipoprotein (HDL) cholesterol levels (n=730; 50.1%).

conclusionsUsing this sample of outpatients followed by GPs in Italy, our study reports a relatively high prevalence of MS and a high prevalence of associated CV and metabolic risk factors in patients with than in those without MS.

Indexed as

cardiovascular riskdiabeteshypercholesterolemiahypertensionMetabolic syndrome (MS)

Identifiers

PMID26331111
PMCPMC4536471
OpenAlexW2171099144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.